T. Rowe Price Health Sciences Fund I Class
THISX
NASDAQ
Weiss Ratings | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | T. Rowe Price | |||
Manager/Tenure (Years) | Ziad Bakri (8) | |||
Website | http://www.troweprice.com | |||
Fund Information | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | T. Rowe Price Health Sciences Fund I Class | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Mar 23, 2016 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 500,000.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.17% | |||
Dividend | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.67% | |||
Asset Allocation | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.11% | |||
Stock | 90.41% | |||
U.S. Stock | 81.27% | |||
Non-U.S. Stock | 9.14% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.14% | |||
Other Net | 9.35% | |||
Price History | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.07% | |||
30-Day Total Return | -3.18% | |||
60-Day Total Return | 1.41% | |||
90-Day Total Return | -4.95% | |||
Year to Date Total Return | 2.83% | |||
1-Year Total Return | -1.69% | |||
2-Year Total Return | 10.65% | |||
3-Year Total Return | 9.88% | |||
5-Year Total Return | 44.25% | |||
Price | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $81.97 | |||
1-Month Low NAV | $81.97 | |||
1-Month High NAV | $85.68 | |||
52-Week Low NAV | $79.37 | |||
52-Week Low NAV (Date) | Dec 19, 2024 | |||
52-Week High NAV | $102.82 | |||
52-Week High Price (Date) | Aug 30, 2024 | |||
Beta / Standard Deviation | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.67 | |||
Standard Deviation | 14.61 | |||
Balance Sheet | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 13.10B | |||
Operating Ratios | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.67% | |||
Turnover Ratio | 52.40% | |||
Performance | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 7.51% | |||
Last Bear Market Total Return | -9.85% | |||